AtaiBeckley Email Format
Biotechnology ResearchNew York, United States51-200 Employees
AtaiBeckley is a clinical-stage biotechnology company based in New York City that aims to advance mental health care by developing treatments that act quickly, last, and are convenient to use. Operating in the biotechnology research industry, it is positioned as a mid-sized firm focused on clinical development. The company arose in 2025 from the combination of atai Life Sciences and Beckley Psytech. Its clinical-stage programs target mental health conditions with significant unmet needs, including treatment-resistant depression and social anxiety disorder. In recent months, the company has been active in industry collaborations and investor forums, and has engaged in partnerships intended to incorporate patient perspectives into research.